Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis - AcademicCME

Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis

1.0

Claim your AMA PRA Category 1 Credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

course Faculty

No data was found

Related Courses

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Pathophysiology, Diagnosis, and ...

FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG): Patient Selectio...

Cardiometabolic

LIVE UPDATE FROM AHA24: What do we know about antiplatelets added to anticoagulation in pa...